Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma

GSK authors: Kihyun Kim, MD; Nick Pirooz, MHA; Astrid McKeown, PhD; Simon McNamara, PhD; Xiangdong Zhou, PhD; Maureen Nichols, BS; Eric Lewis, MD; Rachel Rogers, MS.; Hena Baig, BS; Lydia Eccersley, MB, BS, PhD; Sumita Roy-Ghanta, MD; Joanna Opalinska, MD